GeoVax Labs, Inc.
GOVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $0 | $0 | $0 |
| % Growth | – | -100% | -78.9% | – |
| Cost of Goods Sold | $0 | $21 | $9 | $0 |
| Gross Profit | $4 | -$21 | -$9 | $0 |
| % Margin | 97.6% | – | -11,090.9% | 100% |
| R&D Expenses | $24 | $21 | $9 | $16 |
| G&A Expenses | $5 | $6 | $5 | $4 |
| SG&A Expenses | $5 | $6 | $5 | $4 |
| Sales & Mktg Exp. | $0 | -$0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$21 | -$9 | $0 |
| Operating Expenses | $29 | $6 | $5 | $19 |
| Operating Income | -$25 | -$27 | -$14 | -$19 |
| % Margin | -635.8% | – | -17,207.5% | -4,862.7% |
| Other Income/Exp. Net | $0 | $1 | $0 | $0 |
| Pre-Tax Income | -$25 | -$26 | -$14 | -$19 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$25 | -$26 | -$14 | -$19 |
| % Margin | -632% | – | -17,198.3% | -4,817.2% |
| EPS | -4.82 | -10.22 | -5.52 | -7.3 |
| % Growth | 52.8% | -85.1% | 24.4% | – |
| EPS Diluted | -4.82 | -10.22 | -5.52 | -7.3 |
| Weighted Avg Shares Out | 5 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 5 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$25 | -$27 | -$14 | -$19 |
| % Margin | -629% | – | -17,138.4% | -4,806.9% |